ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Forearm Vascular Relaxation

This study is ongoing, but not recruiting participants.
Information provided by National Institute on Aging (NIA)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Forearm Vascular Relaxation
Official Title  Determinants of Forearm Vascular Relaxation: Role of Genetic Polymorphisms
Brief Summary

The purpose of this study is to learn the effect of inherited differences on forearm blood flow responses to hormones and drugs

Detailed Description

Differences in at least 4 genes are believed to have an important effect on responses to hormones and drugs. For this study, healthy volunteers of normal body weight will be screened to find xxx individuals with the genes of interest. Very small doses of hormones and drugs will be given so that changes in forearm blood flow can be measured, while not causing effects throughout the body. A brachial artery line and venous line will be placed in the study arm so that blood samples may be withdrawn to compare amounts given into the artery and coming out of the vein after circulating through the arm. Forearm blood flow is determined by the rate of swelling of the arm after a blood pressure cuff is inflated (above venous and below arterial blood pressure). The hormones and drugs being studied include angiotensin I, angiotensin II, acetylcholine, sodium nitroprusside, enalaprilat, L-arginine, phenylephrine, endothelin-1, verapamil, and isoproterenol. This procedure will last 4-6 hours. The process will be repeated with the same participant over 2 weeks later.

Study Phase
Study Type  Observational
Study Design  Screening, Cross-Sectional, Defined Population, Prospective Study
Primary Outcome Measure 
Secondary Outcome Measure 
Condition  Healthy
Intervention 
MEDLINE PMIDs 7554707,   2162750,   1602392
Links National Institute on Aging This link exits the ClinicalTrials.gov site
Recruitment Information Fields
Recruitment Status  Active, not recruiting
Enrollment  400
Start Date  May 2003
Completion Date April 2005
Eligibility Criteria 

Inclusion Criteria:

  • Normal physical status without any medical interventions or agents which would alter the defined status of normal

Exclusion Criteria:

  • Age less than 21 or greater than 45
  • Unable to give informed consent
  • BMI (Body Mass Index) less than 18 or greater than 25
  • Clinically significant abnormal laboratory values
  • Abnormal physical exam
  • Abnormal EKG
  • Pregnancy
  • Smoking or drug usage (illicit or otherwise)
  • Post-menopause
  • Participation in another clinical trial in the past month
  • Chronic Illness
Gender Both
Ages 21 Years to 45 Years
Accepts Healthy Volunteers Yes
Contacts ††
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00182923
Organization ID AG0038
Secondary IDs ††
Study Sponsor  National Institute on Aging (NIA)
Collaborators ††
Investigators 
Principal Investigator:     Darrell R. Abernethy, MD, PhD     National Institute on Aging, Laboratory of Clinical Investigation    
Information Provided By National Institute on Aging (NIA)
Verification Date November 2006
First Received Date  September 12, 2005
Last Updated Date November 9, 2006

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers